DPT-Hib vaccine
| Combination of | |
|---|---|
| Diphtheria vaccine | Vaccine |
| Tetanus vaccine | Vaccine |
| Pertussis vaccine | Vaccine |
| Hib vaccine | Vaccine |
| Clinical data | |
| Trade names | Tetramune |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Routes of administration | Intramuscular injection |
| ATC code | |
DPT-Hib vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and whole-cell pertussis vaccine adsorbed with Hib conjugate vaccine, sometimes abbreviated to DPT-Hib.[1] It protects against the infectious diseases diphtheria, tetanus, pertussis, and Haemophilus influenzae type B.
A branded formulation was marketed in the US as Tetramune by Lederle Praxis Biologicals (subsequently acquired by Wyeth).[2] Tetramune has since been discontinued.[3]
References
- ^ "DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE ADSORBED AND HAEMOPHILUS B CONJUGATE VACCINE (Systemic)". Drugs.com. Retrieved 15 July 2018.
- ^ "FDA Approval of Use of a New Haemophilus b Conjugate Vaccine and a Combined Diphtheria-Tetanus-Pertussis and Haemophilus b Conjugate Vaccine for Infants and Children". Morbidity and Mortality Weekly Report. Centers for Disease Control and Prevention. 23 April 1993. pp. 296–298. Retrieved 15 July 2018.
- ^ "Selected Discontinued U.S. Vaccines" (PDF). Centers for Disease Control and Prevention. Retrieved 15 July 2018.
 | This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it. |